Atai Life Sciences N.V., a clinical-stage biopharmaceutical company, develops and invests in various therapeutics to treat depression, anxiety, and other mental health disorders. The company's product candidates include COMP360, BPL-003, an intranasal formulation that is in Phase 2a and 2b clinical studies; TRD; VLS-01, a transmucosal film in Phase 2 clinical study; and ELE-101, a serotonergic psychedelic for the treatment of treatment resistant depression. It also EMP-01, an oral formulation of an R-MDMA that Is in phase 2 clinical study; and EGX-A and EGX-B, psychedelic-like with novel, non-tryptamine structures with differentiated 5-HT receptor pharmacology. In addition, the company offers RL-007, an orally bioavailable compound, which is a pro-cognitive neuromodulator for cognitive impairment associated with schizophrenia; and GRX-917, for the treatment of generalize anxiety disorder. ATAI Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany.

Atai Beckley N.V

Analysts are intrested in these 5 stocks: ( ($SCHW) ), ( ($GPN) ), ( ($USB) ), ( ($TFC) ) and ( ($ATAI) ). Here is a breakdown of their recent


Schwab, GPN, USB, Truist, Atai Beckley Trending With Analysts

Analysts are intrested in these 5 stocks: ( ($ETSY) ), ( ($CTAS) ), ( ($ATAI) ), ( ($UNH) ) and ( ($BROS) ). Here is a breakdown of their recent


Etsy, Cintas, Atai, UnitedHealth, Dutch Bros Trending With Analysts

Berenberg Bank analyst Harry Gillis maintained a Buy rating on Atai Beckley N.V. yesterday and set a price target of $14.00. According to TipRanks,...

Berenberg Bank Sticks to Their Buy Rating for Atai Beckley N.V. (ATAI)

Atai Beckley N.V. received a Hold rating and price target from JonesTrading analyst Justin Walsh today. Walsh covers the Healthcare sector, focusin...

JonesTrading downgrades Atai Beckley N.V. (ATAI) to a Hold

AtaiBeckley N.V. ($ATAI) stock surged on Thursday after the clinical-stage biopharmaceutical company announced an acquisition agreement with global...

Why Is AtaiBeckley N.V. (ATAI) Stock Up Today?

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Atai Beckley N.V. (ATAI) and Climb Bio (CLYM) with b...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ATAI	$7.25	+0.97%	6.41M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ATAI	$7.25	+1.0%	6.41M
3
4
5
6

ATAI

ATAI

Get Atai Beckley N.V Data in Excel

Get Atai Beckley N.V Data in Excel